Table 1 Baseline characteristics of patients with or without multihematoma fuzzy sign before and after propensity score (PS) matching.
Variables | Before PS match | After PS match | ||||
|---|---|---|---|---|---|---|
No multihematoma fuzzy sign (n = 270) | Multihematoma fuzzy sign (n = 212) | P value | No multihematoma fuzzy sign (n = 158) | Multihematoma fuzzy sign (n = 158) | P value | |
Male sex, no. (%) | 204 (75.56%) | 157 (74.06%) | 0.706 | 115 (72.78%) | 117 (74.05%) | 0.799 |
Mean age (SD), y | 50.99 (17.22) | 50.60 (18.17) | 0.808 | 51.32 (17.47) | 50.89 (17.43) | 0.827 |
Hypertension, no. (%) | 29 (11.28%) | 32 (15.69%) | 0.166 | 18 (11.39%) | 21 (13.29%) | 0.608 |
Diabetes, no. (%) | 15 (5.68%) | 15 (7.25%) | 0.490 | 10 (6.33%) | 10 (6.33%) | 1.000 |
Mean arterial pressure, median (IQR) (mmHg) | 100.00 (90.75–109.83) | 103.00 (94.00–113.66) | 0.008 | 100.00 (91.00–110.00) | 100.00 (91.75–110.00) | 0.698 |
Coagulopathy, no. (%) | 42 (16.03%) | 35 (16.91%) | 0.799 | 26 (16.46%) | 27 (17.09%) | 0.880 |
Level on Glasgow Coma Scale score, no. (%) | 0.241 | 0.858 | ||||
Mild (13–15 points) | 142 (52.59%) | 100 (47.17%) | 81 (51.27%) | 83 (52.53%) | ||
Moderate (9–12 points) | 53 (19.63%) | 55 (25.94%) | 36 (22.78%) | 32 (20.25%) | ||
Severe (3–8 points) | 75 (27.78%) | 57 (26.89%) | 41 (25.95%) | 43 (27.22%) | ||
Location, no. (%) | < 0.001 | 0.974 | ||||
Frontal | 109 (40.37%) | 125 (58.96%) | 86 (54.43%) | 80 (50.63%) | ||
Temporal | 127 (47.04%) | 76 (35.85%) | 61 (38.61%) | 67 (42.41%) | ||
Parietal | 9 (3.33%) | 7 (3.30%) | 7 ( 4.43%) | 7 ( 4.43%) | ||
Occipital | 12 (4.44%) | 2 (0.94%) | 2 ( 1.27%) | 2 ( 1.27%) | ||
Basal ganglia, brainstem, or cerebellum | 13 (4.81%) | 2 (0.94%) | 2 ( 1.27%) | 2 ( 1.27%) | ||
Intraventricular hemorrhage, no. (%) | 22 (8.15%) | 18 (8.49%) | 0.892 | 11 ( 6.96%) | 11 ( 6.96%) | 1.000 |
Subarachnoid hemorrhage, no. (%) | 213 (78.89%) | 189 (89.15%) | 0.003 | 137 (86.71%) | 136 (86.08%) | 0.870 |
Subdural hemorrhage, no. (%) | 189 (70.00%) | 180 (84.91%) | < 0.001 | 127 (80.38%) | 127 (80.38%) | 1.000 |
Time to baseline CT (IQR) (h) | 2.50 (1.50–4.00) | 2.17 (1.50–4.00) | 0.148 | 2.37 (1.50–4.27) | 2.60 (1.67–4.24) | 0.672 |
Time from baseline CT to follow-up CT (IQR) (h) | 16.66 (9.87–24.00) | 16.25 (8.59–24.00) | 0.967 | 15.59 (7.08–24.00) | 17.00 (8.10–24.00) | 0.490 |
Baseline tICH volume, mean (SD) (ml) | 7.70 (8.29) | 10.96 (11.10) | < 0.001 | 8.29 (8.99) | 8.96 (7.42) | 0.470 |
